Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
51.45
+0.27 (0.53%)
At close: Jul 16, 2026
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
$773,849
Profits / Employee
$157,320
Market Cap
327.06B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Veradigm | 2,300 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 105 |
| Silence Therapeutics | 88 |
| Elite Pharmaceuticals | 65 |
| Vaxart | 65 |
| CytoDyn | 13 |
Roche Holding AG News
- 1 day ago - Genentech granted priority review for Gazyva sBLA by FDA - TheFly
- 2 days ago - FDA grants Priority Review to Roche's Gazyva/Gazyvaro for adults with primary membranous nephropathy - GlobeNewsWire
- 2 days ago - FDA Grants Priority Review to Genentech's Gazyva for Adults With Primary Membranous Nephropathy - Business Wire
- 3 days ago - Roche introduces cobas Hepatitis D Virus (HDV) test, the first fully automated diagnostic solution to identify the most severe form of viral hepatitis - GlobeNewsWire
- 8 days ago - Roche receives CE Mark for blood test to identify tuberculosis infection - TheFly
- 8 days ago - Roche receives CE Mark for blood test to identify tuberculosis infection - GlobeNewsWire
- 8 days ago - The Market Just Got Shaken—These 3 ETFs May Come Out Stronger - MarketBeat
- 10 days ago - Genentech and Roche Present New Data in Alzheimer's Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC - Business Wire